Convexia develops AI agents that evaluate drug assets through simulations, clinical profiling, safety prediction, and market analysis.
Convexia has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2025.
Convexia's investors include Y Combinator, Rebel Fund.
Convexia is headquartered in San Francisco, United States.
Convexia develops AI agents that evaluate drug assets through simulations, clinical profiling, safety prediction, and market analysis.
Convexia is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Convexia — Funding & Investors." VCBacked, September 9, 2025, https://www.vcbacked.co/company/convexia. Accessed July 20, 2026.
VCBacked. (2025). Convexia — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/convexia
{{cite web |title=Convexia — Funding & Investors |url=https://www.vcbacked.co/company/convexia |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated